Skip to main content
SpringerLink
Log in

Anti-DNA and Antiphospholipid Antibodies in IVIG Preparations: In Vivo Study in Naive Mice

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Intravenous immunoglobulins (IVIG) are therapeutic preparations of pooled normal polyspecific immunoglobulin G. We investigated the presence and the in vivo pathogenic potential of autoantibodies against phospholipids and DNA in several commercial IVIG preparations. The presence of autoantibodies and their antiidiotypic antibodies in the IVIG preparations was detected by ELISA. Naive mice were actively immunized with either IVIG preparations or pathogenic monoclonal antibodies (mAbs) against cardiolipin (CL) or DNA, in an attempt to induce autoimmune conditions. The mice were tested for the presence of mouse autoantibodies (auto-Abs) and for clinical parameters of autoimmune diseases. We found high levels of auto-Abs against a panel of phospholipids and DNA, as well as their antiidiotypic Abs, in all the IVIGs. Affinity studies pointed to a lower affinity of auto-Abs of IVIG origin to their respective antigens compared to pathogenic mAbs. Mice immunized with pathogenic anti-CL mAb had high levels of antiphospholipid auto-Abs, accompanied by thrombocytopenia, prolonged aPTT, and an increased fetal resorption rate. Mice immunized with pathogenic anti-DNA mAb had elevated anti-DNA and anti-CL auto-Abs, along with a high erythrocyte sedimentation rate, leukopenia, and significant proteinuria. Following immunization with IgGs from IVIG batches, mice developed high levels of auto-Abs against phospholipids and DNA, similar to mice immunized with pathogenic anti-DNA or anti-CL mAbs, but none of the mice expressed the clinical manifestations compatible with the presence of these autoantibodies. We conclude that commercial IVIG preparations contain high levels of antiphospholipid and anti-DNA auto-Abs, as well as their antiidiotypic Abs. Although these Abs induced the generation of mouse auto-Abs upon active immunization, following idiotypic manipulation they did not prove to be pathogenic in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Greenberg AH: Antibodies and natural immunity. Biomed Pharmacother 39:4–6, 1985

    Google Scholar 

  2. Shoenfeld Y, Isenberg DA (eds): Natural Autoantibodies, Their Physiological Role and Regulatory Significance. Boca Raton, FL, CRC Press, 1993

    Google Scholar 

  3. Shoenfeld Y, Isenberg DA: The Mosaic of Autoimmunity, the Factors Associated with Autoimmune Diseases. Amsterdam, Elsvier, 1989

    Google Scholar 

  4. Shoenfeld Y: Pathogenic natural autoantibodies. Isr J Med Sci 29:42–145, 1992

    Google Scholar 

  5. Tincani A, Balesterieri G, Allegri F, Cattaneo R, Fornasieri A, Sinico A, D'Amico G: Induction of experimental SLE in naive mice by immunization with human polyclonal anti-DNA antibody carrying the 16/6 idiotype. Clin Exp Rheumatol 11:129–134, 1994

    Google Scholar 

  6. Dang H, Noriyoshi O, Takei M, Lazaridis K, Talal N: Induction of lupus associated autoantibodies by immunization with native and recombinant Ig peptides expressing a cross-reactive idiotype 4B4. J Immunol 151:7260–7267, 1993

    Google Scholar 

  7. Rombach E, Stetler DA, Brown JC: Rabbits produce SLE-like anti-RNA polymerase I and anti-DNA autoantibodies in responses to immunization with either human or murine SLE anti-DNA antibodies. Autoimmunity 13:291–302, 1992

    Google Scholar 

  8. Mendelovic S, Brocke S, Shoenfeld Y, Ben-Bassat M, Meshorer A, Bakimer R, Mozes E: Induction of SLE like disease in mice by a common anti-DNA idiotype. Proc Natl Acad Sci USA 85:2260–2264, 1988

    Google Scholar 

  9. Blank M, Krup M, Mendelovic S, Fricke H, Mozes E, Talal N, Coates ARM, Shoenfeld Y: The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice. Scand J Immunol 31:45–52, 1990

    Google Scholar 

  10. Blank M, Mendelovic S, Mozes E, Shoenfeld Y: Induction of SLE like disease in naive mice with a monoclonal anti-DNA antibody derived from a patient with polymyositis carrying 16/6 Id. J Autoimmun 1:683–689, 1988

    Google Scholar 

  11. Branch DW, Dudley DJ, Mitchell MD, Abbott KA, Hammond E, Dayness RA: Immunoglobulin G fraction from patients with anti-phospholipid antibodies causes fetal death in Balb/c mice: A model for autoimmune fetal loss. Am J Obstet Gynecol 163:210–217, 1990

    Google Scholar 

  12. Blank M, Cohen J, Toder V, Shoenfeld Y: Induction of primary anti-phospholipid syndrome by anti-cardiolipin antibodies. Proc Natl Acad Sci USA 88:3069–3073, 1991

    Google Scholar 

  13. Bakimer R, Fishman P, Blank M, Sredni B, Djaldetti M, Shoenfeld Y: Induction of primary anti-phospholipid syndrome in mice by immunization with human monoclonal anti-cardiolipin antibody (H-3). J Clin Invest 89:1558–1563, 1992

    Google Scholar 

  14. Blank M, Tincani A, Shoenfeld Y: Induction of experimental anti-phospholipid syndrome in naive mice with purified IgG anti-phosphatidylserine antibodies. J Rheumatol 21:100–104, 1994

    Google Scholar 

  15. Blank M, Krause I, Ben-Bassat M, Shoenfeld Y: Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J Autoimmun 5:495–502, 1992

    Google Scholar 

  16. Cohen J, Bakimer R, Blank M, Valesini G, Shoenfeld Y: Pathogenic natural anti-cardiolipin antibodies: The experience from monoclonal gammopathy. Clin Exp Immunol 97:181–186, 1994

    Google Scholar 

  17. Jerne NK: Toward a network theory of the immune system. Ann Immunol 125:373–389, 1974

    Google Scholar 

  18. Jerne NK, Roland J, Cazenava PA: Recurrent idiotypes and internal images. EMBO J 1:243–247, 1982

    Google Scholar 

  19. Shoenfeld Y: Idiotypic induction of autoimmunity: A new aspect of the idiotypic network. FASEB J 8:1296–1301, 1994

    Google Scholar 

  20. Tomer Y, Gilburd B, Blank M, Lider O, Hershkoviz R, Fishman P, Zigelman R, Meroni PL, Wiik A, Shoenfeld Y: Characterization of biologically active antineutrophil cytoplasmic antibodies induced by mice. Arth Rheum 38:1375–1381, 1995

    Google Scholar 

  21. Blank M, Tomer Y, Stein M, Kopolovic J, Wiik A, Meroni PL, Conforty G, Shoenfeld Y: Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 102:120–130, 1995

    Google Scholar 

  22. Berkman SA, Lee ML, Gale RP: Clinical uses of intravenous immunoglobulins. Semin Hematol 25:140–158, 1988

    Google Scholar 

  23. Arsura EL, Bick A, Brunner NG, Grob D: Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. Am J Med Sci 295:438–443, 1988

    Google Scholar 

  24. Jayne DRW, Davies M, Fox C, Lockwood CM: Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 2:1137–1139, 1991

    Google Scholar 

  25. Bakimer R, Guilbrud B, Zurgil N, Shoenfeld Y: The effect of intravenous-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol 69:97–102, 1993

    Google Scholar 

  26. Parker A: The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. Clin Rev Allergy 10:105–118, 1992

    Google Scholar 

  27. Akashi K, Nagasawa K, Myumi T, Yokota E, Oochi N, Jusaba T: Successful treatment of refractory systemic lupus erythematosus with intravenous immunoglobulins. J Rheumatol 17:375–379, 1990

    Google Scholar 

  28. Tomer Y, Shoenfeld Y: Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10:391–393, 1992

    Google Scholar 

  29. Schroeder JO, Zeuner RA, Euler HH, Loffler H: High dose intravenous immunoglobulins in systemic lupus erythematosus: Clinical and serological results of a pilot study. J Rheumatol 23:71–75, 1996

    Google Scholar 

  30. Fehr J, Hoffmaan V, Kappeler U: Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous immunoglobulin. N Engl J Med 306:1254–1258, 1982

    Google Scholar 

  31. Achiron A, Margalit R, Hershkoviz R: Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. J Clin Invest 93:600–605, 1994

    Google Scholar 

  32. Andersson U, Bojork L, Skanson-Saphir U, Andersson J: Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 139:5–20, 1994

    Google Scholar 

  33. Dietrich G, Kazatchkine MD: Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies. J Clin Invest 85:620–625, 1990

    Google Scholar 

  34. Rossi F, Jayne DR, Lockwood CM, Kazatchkine MD: Antiidiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis. Clin Exp Immunol 83:298–303, 1991

    Google Scholar 

  35. Kazatchkine MD, Rossi F, Sultan Y, Nydegger UE: Anti-idiotypes against autoantibodies to procoagulant factor VIII in IVIG. Int Rev Immunol 5:157–163, 1989

    Google Scholar 

  36. Rossi F, Kazatchkine MD: Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 143:4104–4109, 1989

    Google Scholar 

  37. Evans MJ, Suenaga R, Abdou NI: Detection and purification of antiidiotypic antibodies against anti-DNA in intravenous immune globulin. J Clin Immunol 11:291–295, 1991

    Google Scholar 

  38. Silvestris F, Cafforio P, Dammacco F: Pathogenic anti-DNA idiotype-reactive IgG in intravenous immunoglobulin preparations. Clin Exp Immunol 97:19–25, 1994

    Google Scholar 

  39. Berchtold P, Dale GL, Tani P, McMillan R: Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin. Blood 74:2414–2417, 1989

    Google Scholar 

  40. Ayliffe W, Haeney M, Roberts SC, Lavin M: Uveitis after antineutrophil cytoplasmic antibody contamination of immunoglobulin replacement therapy. Lancet 339:558–559, 1992 (letter).

    Google Scholar 

  41. Vogele C, Andrassy K, Schmidbauer JM, Krastel H, Adler D, Ritz E: Retinal vasculitis and uveitis—An adverse reaction to intravenous immunoglobulin? Nephron 67:363, 1994

    Google Scholar 

  42. Brox AG, Cournoyer D, Sternbach M, Sprull G: Hemolytic anemia following intravenous gammaglobulin administration. Am J Med 93:114–115, 1993

    Google Scholar 

  43. Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM: Immune hemolysis, disseminated intravascular coagulation and serum sickness after large dose of immune globulin given intravenously for Kawasaki disease. J Pediatr 120:926–928, 1992

    Google Scholar 

  44. Parham P: Preparation and purification of active fragments from mouse monoclonal antibodies. In Handbook of Experimental Immunology, Vol 2. Cellular Immunology, L Herzenberg, C Blackwell, L Herzenberg (eds). Oxford, Blackwell Scientific, p 14

  45. Pullen GRM, Fitzgerald MG, Hoshing CS: Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 86:83–87, 1986

    Google Scholar 

  46. MacDonald RA, Hoshing CS, Jones CL: The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods 106:191–194, 1988

    Google Scholar 

  47. Hohmann A, Comacchio R, Boswarva V, Sutjita M, Bradley J: The H-3 anti-phospholipid idiotype is found in patients with SLE but not in patients with syphilis. Clin Exp Immunol 86:207–211, 1989

    Google Scholar 

  48. Krause I, Blank M, Kopolovic J, Afek A, Goldberg I, Tomer Y, Shoenfeld Y: Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. J Rheumatol 22:1068–1074, 1995

    Google Scholar 

  49. Gleicher N, Harlow BS: Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations. Mt. Sinai J Med 57:242–248, 1990

    Google Scholar 

  50. Saenko VA, Kabakov AE, Poverenny AM: Hidden high-avidity anti-DNA antibodies occur in normal human gammaglobulin preparations. Immunol Lett 34:1–5, 1992

    Google Scholar 

  51. Adib M, Ragimbeau J, Avrameas S, Ternynck T: IgG autoantibody activity in normal mouse serum is controlled by IgM. J Immunol 145:3807–3813, 1990

    Google Scholar 

  52. Kra-Oz Z, Lorber M, Shoenfeld Y, Scharff Y: Inhibitor(s) of natural anti-cardiolipin autoantibodies. Clin Exp Immunol 93:265–268, 1993

    Google Scholar 

  53. Lorber M, Kra-Oz Z, Guilbrud B, Shoenfeld Y: Natural (antiphospholipid,-PDH,-DNA) autoantibodies and their physiologic serum inhibitors. Isr J Med Sci 31:31–35, 1995

    Google Scholar 

  54. Donatini B, Goetz J, Hauptmann G: Uveitis and antineutrophil cytoplasmic antibody in immunoglobulin. Lancet 339:1175–1176, 1992

    Google Scholar 

  55. Barton JC, Herrera GA, Galla JH, Bertoli LF, Work J, Koopman WJ: Acute cryoglobulinemic renal failure after intravenous infusion of gamma globulin. Am J Med 82:624–629, 1987

    Google Scholar 

  56. Tam DA, Morton LD, Stronek DF, Leshner RT: Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 64:175–178, 1996

    Google Scholar 

  57. Lassiter HA, Bibb KW, Bertolone SJ, Patel CC, Stronek DF: Neonatal immune neutropenia following the administration of intravenous immune globulin. Am J Pediatr Hematol Oncol 15:120–123, 1993

    Google Scholar 

  58. Vassilev T, Gelin C, Kaveri SV, Zilber MT, Boumsell L, Kazatchkin MD: Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (IVIG). Clin Exp Immunol 92:369–372, 1993

    Google Scholar 

  59. Fishman P, Falach-Vaknin E, Zigelman R, Bakimer R, Sredni B, Djaldeti M, Shoenfeld Y: Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3. J Clin Invest 91:1834–1837, 1993

    Google Scholar 

  60. Shoenfeld Y, Fishman P: Role of IL-3 in the antiphospholipid syndrome. Lupus 3:259–261, 1994

    Google Scholar 

  61. Blank M, Mendlovic S, Mozes E, Coates ARM, Shoenfeld Y: Induction of systemic lupus erythematosus in naive mice with T-cell lines specific for human anti-DNA antibody SA-1 (16/6 Id+) and for mouse tuberculosis antibody TB/68 (16/6 Id+). Clin Immunol Immunopathol 60:471–483, 1991

    Google Scholar 

  62. Blank M, Krause I, Buskila D, Teitelbaum D, Kopolovic J, Afek A, Goldberg I, Shoenfeld Y: Bromocriptine immunomodulation of experimental SLE and primary anti-phospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol 162:114–122, 1995

    Google Scholar 

  63. Blank M, Ben-Bassat M, Shoenfeld Y: Modulation of SLE induction in naive mice by specific T cells with suppressor activity to pathogenic anti-DNA idiotype. Cell Immunol 137:474–486, 1991

    Google Scholar 

  64. Kazatchkin MD, Dietrich G, Hurez V, Ronda N, Bellon B, Rossi F, Kaveri SV: V Region-mediated selection of autoreactive repertoires by intravenous immunoglobulin. Immunol Rev 139:79–107, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Unit of Autoimmune Diseases, Department of Medicine “B,” Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer 52621, Israel

    Ilan Krause, Miri Blank & Yehuda Shoenfeld

Authors
  1. Ilan Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miri Blank
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yehuda Shoenfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krause, I., Blank, M. & Shoenfeld, Y. Anti-DNA and Antiphospholipid Antibodies in IVIG Preparations: In Vivo Study in Naive Mice. J Clin Immunol 18, 52–60 (1998). https://doi.org/10.1023/A:1023239904856

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023239904856

Search

Navigation